Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAF1 pseudogene 1 (RAF1P1) is a non-coding sequence in the human genome that is homologous to the protein-coding RAF1 gene (also known as c-Raf or v-raf-1 murine leukemia viral oncogene homolog 1). As a pseudogene, RAF1P1 does not encode a functional protein and has no established biological function, molecular activity, or role as a therapeutic target. It should not be confused with the canonical and active RAF1 gene, which codes for a serine/threonine kinase of major significance in cell signaling and oncogenesis. No current evidence implicates RAF1P1 (the pseudogene) in disease, biomarker use, drug interaction, or safety concern. The protein-coding gene RAF1 is distinct and acts as a serine/threonine kinase in the MAPK pathway, playing roles in cell proliferation, cell survival, and is commonly targeted in cancer research and therapy. Pseudogenes such as RAF1P1 are often remnants of genome evolution and are not targets for drugs or disease research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAF1 pseudogene 1 (RAF1P1).